Navigation Links
MAQUET Cardiovascular Responds to Terumo Complaint About VASOVIEW Endoscopic Vessel Harvesting Systems
Date:9/2/2008

SAN JOSE, Calif., Sept. 2 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that it was served with a complaint filed by Terumo Cardiovascular Systems Corp. (Terumo CSC) in the United States District Court for the Northern District of California. The complaint alleges that MAQUET's VASOVIEW Endoscopic Vessel Harvesting Systems infringe a certain U.S. patent.

In April 2008, MAQUET filed patent infringement complaints against Terumo CSC and Terumo Corporation with the International Trade Commission (ITC) and in the United States District Court for the Northern District of California, alleging that Terumo's VirtuoSaph(TM) endoscopic vessel harvesting system infringes two MAQUET U.S. patents. The ITC case seeks to exclude the infringing products from importation into the United States and the district court case seeks monetary damages and an injunction. The complaint filed by Terumo will not affect the actions filed by MAQUET.

MAQUET will continue to protect and enforce its intellectual property rights, and will aggressively defend the law suit filed by Terumo.

About MAQUET Cardiovascular

MAQUET Cardiovascular LLC is a division within the Medical Systems business, part of the publicly listed Swedish group of companies GETINGE AB. MAQUET Cardiovascular was formed by combining MAQUET Cardiopulmonary with Boston Scientific's Vascular Surgery and Cardiac Surgery divisions, which included the products and services of Guidant Cardiac Surgery. The creation of this new organization enables MAQUET to offer a comprehensive array of patient care solutions for less-invasive endoscopic vessel harvesting, off- and on- pump coronary artery bypass surgery, and vascular grafts.

MAQUET has 170 years of healthcare experience, and is committed to becoming "The Gold Standard" for therapeutic medical equipment across the globe. As a market leader, MAQUET offers innovative medical solutions from three divisions: Surgical Workplaces, Critical C
'/>"/>

SOURCE MAQUET Cardiovascular LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
2. MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
3. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
4. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
5. Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
6. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
7. New discovery may lead to immunization against cardiovascular disease
8. Geneva Offers First Cardiovascular Technology Graduate Program in the Nation
9. Leading worldwide cause of cardiovascular disease may be modified by diet
10. Building a Fully Integrated Cardiovascular Imaging and Information System Webinar
11. Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Specialist manufacturers who...ucts are saving millions of dollars by bringing in...ocess. Increasing numbers of pro-active medical ma...ts at the concept stage of their projects, ensurin...g design processes or potentially outdated technol...
(Date:11/26/2009)... , PRINCETON, N.J., Nov. 27 ... almost double over the next 25 years and annual m... $336 billion, up from $113 billion today, accordi...Diabetes Care . The National Changing Diabetes &...ommissioned the analysis by a team from the Univer...
(Date:11/26/2009)...age that,s too big or too heavy can lead to strain...Day News) -- There may be nothing wrong with stuff...t want to do the same thing with your suitcase as ...people were treated in 2008 in U.S. hospital emerg...dical facilities for luggage-related injuries, suc...
(Date:11/26/2009)... Dr. David Kim of the Live Li...surgery in Dallas , is one of a growing number of ...cial networking sites to connect with individuals ...nt to fight morbid obesity. Dr. Kim is utilizing F...mation about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is o... for users of Yaz and Yasmin birth control pills w...monary Embolism, Stroke, Heart Attack or other rel...ed. Women can call toll free at 1-800-856-6405 or ...slaw.com and fill out an online case evaluation f...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...g in the October issue of the journal Pediatrics s...lk is more than that of Cow's milk. Dr. Ruth...New York and her colleague Dr. William H. Bowen us... when they were fed sweet liquids like soda and ho...
...ed in the treatment of Multiple Sclerosis (MS), ha...s taking the drug complained of neurological disor...gressive Multifocal Leukoencephalopathy (PML) is b...h work by blocking passage of immune cells in to t...
...rize meant swallowing a glassful of dangerous bact...ssor Barry Marshall however did just that. He swal...ach ulcers are bacterial in origin rather than str...ates for Medicine in the current year. "I didn't t...
...10 countries estimated to have the highest number ...US following closely. Type II Diabetes, one of the...ining // epidemic proportions throughout the world...idity and mortality due to long-term micro and mac...
...as advanced so much to the extent of replacing los...ing artificial implants. These implantable devices...od // alternative to the conventional treatment. ...ality of these tiny, yet useful devices. Designed ...
... been reported at a seniors' home in Toronto and e... have caused the death of four residents at the ho... that there was // no cause to fear an outbreak an... a significant burden of disease," he said. All th...
Other Medicine News:Health News:Nobel For Ulcer-Defying Aussie Scientists 2Health News:A new anti diabetic drug on the anvil 2Health News:Implantable devices to be powered by organosilicon compounds in the future 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinke...is available in its catalogue: ,, Intranasal D...ttp://www.reportlinker.com/p0164267/Intranasal-Dru..., The US intranasal drug delivery market is witnes... the delivery of conventional local therapeutic dr...
(Date:11/25/2009)... FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNewswire...aq: HTWR ; ASX: HIN), a leading innovator and pro...upport technologies revolutionizing the treatment ... is scheduled to make an investor presentation at ...ce at 8:00 am EST on Wednesday, December 2, 2009. ...
(Date:11/24/2009)..., BETHESDA, Md., Nov. 24 /PRNewswire-Asia/ -... CHDX ), a leading independent American provider ... People,s Republic of China, today,announced that ...ray,"Unplugged" Health Care Conference, to be held...l. , Management is currently scheduled to...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Chindex International to Present at Piper Jaffray Health Care Conference 2Mass General team develops potentially safer general anesthetic 52483 1Mass General team develops potentially safer general anesthetic 52483 2Frost 26 Sullivan Recognizes MIRTEC With the 2009 Award for Automated Optical Inspection Product Innovation of the Year 9325 1Frost 26 Sullivan Recognizes MIRTEC With the 2009 Award for Automated Optical Inspection Product Innovation of the Year 9325 2Frost 26 Sullivan Recognizes MIRTEC With the 2009 Award for Automated Optical Inspection Product Innovation of the Year 9325 3KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 1KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 2KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 3
...Successful and seamless completion of clinical tri...ened to randomized patients, market research, an e...ent guided by real time metrics. , , MediciGloba...chievable when clinical trial sites are engaged an...great team chemistry with the study sponsor -- a m...
...atRx Pharmaceuticals, a privately-held biopharmace...ted enrollment in the Company,s second pivotal Pha...blets). Together with the previously completed fir...any has fully enrolled its planned pivotal Phase 3...gen-free oral therapy currently in development for...
Other Medicine Technology:Major Restless Legs Study Completes Enrollment With Support From MediciGlobal 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: